Available Dosages
| SKU: | 28 |
|---|---|
| Generic For: | Zyloprim |
| Active Ingredient: | Allopurinol |
Buy Zyrik 300mg (Allopurinol) Online
For the patient who has been living with gout for years — whose joints have been attacked repeatedly despite dietary changes, who wakes up to the telltale warmth and swelling in a toe or ankle, and who may be developing the firm, chalky deposits under the skin known as tophi — Zyrik 300mg represents the turning point. It is the standard maintenance dose of Allopurinol, a xanthine oxidase inhibitor that addresses the root cause of gout by blocking uric acid production at its source. Where the 100mg starting dose establishes tolerability and initiates urate reduction, the 300mg dose delivers sustained, meaningful uric acid lowering that dissolves existing crystal deposits, prevents new joint attacks, and — over months and years of continuous therapy — progressively reverses the accumulated burden of undertreated hyperuricaemia. Zyrik 300mg is also the standard dose used in oncology to prevent tumour lysis syndrome, one of the most dangerous metabolic complications of cancer chemotherapy. This is long-term disease management at its most effective.
What is Zyrik 300mg?
Zyrik 300mg is an oral tablet containing Allopurinol 300mg, a xanthine oxidase inhibitor used as the standard maintenance dose for the long-term management of gout, chronic hyperuricaemia, and recurrent uric acid nephrolithiasis (kidney stones). It is also the dose routinely deployed in the prophylaxis and management of tumour lysis syndrome. This potentially life-threatening metabolic emergency occurs when rapid destruction of malignant cells during chemotherapy floods the bloodstream with purines, causing acute hyperuricaemia, acute renal failure, and cardiac arrhythmias. Manufactured by Sun Pharma, Zyrik 300mg is the dose at which most gout patients achieve and sustain a serum uric acid level below the 6 mg/dL threshold — the biochemical target at which monosodium urate crystals dissolve rather than accumulate, and the foundation of all modern gout treatment strategies.
Manufacturer: Zyrik 300mg is manufactured by Sun Pharma (Sun Pharmaceutical Industries Ltd.), India’s largest pharmaceutical company and a globally trusted producer of high-quality rheumatology and nephrology medications with extensive international distribution and regulatory approvals across multiple markets.
Key Ingredients of Zyrik 300mg and Their Working Process
Allopurinol 300mg and its pharmacologically active metabolite, Oxypurinol, together achieve comprehensive xanthine oxidase inhibition at this dose:
- Deep XO inhibition and significant urate reduction: At 300mg, Allopurinol — rapidly converted to the long-acting metabolite Oxypurinol in the liver and gut — produces xanthine oxidase inhibition sufficient to reduce serum uric acid by 40–70% compared to pre-treatment baseline. This is dramatically more effective than the 20–30% reduction seen at 100mg, translating into a serum uric acid fall that brings the majority of gout patients below the 6 mg/dL crystal dissolution threshold and into sustained clinical remission.
- Monosodium urate crystal dissolution — the critical long-term mechanism: When serum uric acid is maintained consistently below 6 mg/dL (below 5 mg/dL in tophaceous gout), thermodynamic equilibrium shifts: existing monosodium urate crystals in joints, bursae, tendons, and soft tissues begin to dissolve back into solution. This process is gradual — measurable tophus reduction typically begins after 6–12 months and continues over 2–5 years — but is progressive and leads to complete crystal clearance in the majority of patients who maintain serum urate at target. This dissolution is unique to urate-lowering therapies; no anti-inflammatory drug produces it.
- Mobilisation flares — a paradoxical sign of success: As established crystal deposits dissolve, urate is transiently released into the synovial fluid of adjacent joints, which can trigger acute gout flares during the first 3–6 months of Allopurinol 300mg therapy. This is not treatment failure — it is direct evidence that crystal dissolution is occurring. Concurrent prophylactic low-dose colchicine prescribed during dose escalation is specifically intended to manage this transient mobilisation phenomenon.
- Tumour lysis syndrome prevention: In haematological malignancies (leukaemia, lymphoma) and high-burden solid tumours receiving cytotoxic chemotherapy, rapid cell death releases massive quantities of intracellular purines. Without prophylaxis, the resulting surge in xanthine oxidase activity produces acute severe hyperuricaemia, uric acid crystal precipitation in the renal tubules, acute obstructive uropathy, and potentially fatal hyperkalaemia and cardiac arrhythmias. Allopurinol 300mg started 24–48 hours before chemotherapy blocks this surge, protecting renal function and preventing the metabolic emergency.
- Oxypurinol’s pharmacological role — why once-daily dosing works: Unlike the parent compound Allopurinol (plasma half-life 1–3 hours), Oxypurinol persists in the body for 18–30 hours. This sustained active metabolite provides continuous xanthine oxidase inhibition throughout the full 24-hour dosing interval. Once-daily Allopurinol dosing is effective precisely because the long-acting Oxypurinol carries the therapeutic work that Allopurinol is rapidly converted into
Clinical Uses of Allopurinol 300mg
Allopurinol 300mg is used across rheumatological, nephrological, and oncological settings, making it one of the few medications spanning multiple specialities:
- Chronic Tophaceous Gout: Tophi — visible, palpable deposits of urate crystals — represent years of inadequately controlled hyperuricaemia. They cause joint destruction, chronic low-grade inflammation, and accelerate cardiovascular risk through systemic inflammatory burden. Sustained serum urate below 5 mg/dL with Allopurinol 300mg (or higher if needed) progressively dissolves tophi over 12–36 months, reducing joint damage, restoring function, and eliminating the cardiovascular risk contribution of chronic gouty inflammation.
- Prevention of Recurrent Gout Attacks: International guidelines (ACR 2020, EULAR 2016) recommend urate-lowering therapy for patients with two or more gout flares per year, one or more tophi, or gout with radiographic joint damage. The urate target is below 6 mg/dL — typically requiring 300mg or higher to achieve in most patients. Sustained urate control at this level reduces attack frequency by over 80% after 12 months of treatment.
- Uric Acid Nephrolithiasis (Recurrent Kidney Stones): Recurrent uric acid kidney stones form in persistently acidic urine when urinary urate concentration exceeds solubility. Allopurinol 300mg reduces both serum and urinary urate, simultaneously addressing the primary driver of uric acid stone recurrence.
- Tumour Lysis Syndrome Prophylaxis: Standard of care in haematological malignancy treatment protocols — Allopurinol 300mg daily (or divided dosing for high-risk patients) is initiated 24–48 hours before cytotoxic chemotherapy and continued for 3–7 days after the last dose of chemotherapy, depending on protocol
- Hyperuricaemia Secondary to Diuretics or Chronic Kidney Disease: Thiazide and loop diuretics reduce renal urate excretion, elevating serum uric acid. Allopurinol 300mg corrects diuretic-induced hyperuricaemia and prevents gout and renal stone formation in patients requiring long-term diuretic therapy — a common scenario in hypertension and heart failure management.
Related strengths and products: AllDayChemist carries Zyrik 100mg as the safe initiation and dose-escalation step before reaching the 300mg maintenance dose. For comprehensive joint and musculoskeletal health support alongside gout therapy, AllDayChemist offers a broad range of rheumatology and anti-inflammatory medications.
Key Benefits of Zyrik 300mg
- Achieves the urate dissolution target — below 6 mg/dL in the majority of gout patients; below 5 mg/dL in tophaceous gout
- Progressively dissolves tophi — sustained 300mg therapy leads to measurable tophus reduction over 12–36 months
- Reduces gout attack frequency by over 80% after 12 months of continuous treatment at target urate levels
- Prevents uric acid kidney stones — reduces both serum and urinary urate, addressing the primary nephrolithiasis driver
- Essential in oncology — the standard prophylactic and treatment dose against tumour lysis syndrome
- Once-daily dosing — Oxypurinol’s 18–30 hour half-life ensures 24-hour sustained xanthine oxidase inhibition
- Addresses root cause — eliminates urate crystal burden rather than managing individual attacks with analgesics
- Cost-effective long-term therapy from Sun Pharma — high-quality generic Allopurinol at accessible, sustainable prices
Usage warnings and precautionary advice for using Allopurinol 300mg
- Allopurinol Hypersensitivity Syndrome (AHS): A rare but severe reaction — presenting as a widespread severe rash (including Stevens-Johnson syndrome or toxic epidermal necrolysis), fever, eosinophilia, hepatitis, and renal failure — that occurs predominantly in the first 3 months of therapy. AHS is strongly associated with the HLA-B*58:01 genetic variant, which is more prevalent in Han Chinese, Thai, and Korean populations. Pharmacogenomic testing before starting therapy is recommended in high-risk ethnic groups. Stop Allopurinol immediately if any rash develops and seek urgent medical attention.
- Renal impairment: Oxypurinol is excreted by the kidneys — dose reduction is mandatory in patients with eGFR below 30 mL/min. Patients with significant renal impairment should not exceed 100mg daily without specialist review
- Critical drug interaction — azathioprine and 6-mercaptopurine: Both drugs are metabolised by xanthine oxidase. When Allopurinol inhibits XO, plasma levels of azathioprine and 6-MP rise dramatically — potentially causing severe, life-threatening bone marrow suppression. If co-prescription is unavoidable, doses of azathioprine or 6-MP must be reduced to 25–33% of their normal dose. Always inform all treating physicians and pharmacists that you are taking Allopurinol
- Other interactions: Allopurinol interacts with ampicillin and amoxicillin (increased rash frequency), theophylline (increased theophylline levels), ciclosporin, and warfarin (increased anticoagulant effect — monitor INR closely)
- Do not initiate during acute attack — see dosage guidance above
- Hydration: Maintain fluid intake of 2–3 litres per day to prevent xanthine crystalluria
- Store below 25°C in a dry place, away from light; keep out of reach of children
Side effects of Allopurinol 300mg
Allopurinol is generally well tolerated during long-term maintenance use. Side effects include:
- Common: Gout mobilisation flares in the first 3–6 months as existing crystal deposits dissolve (expected and manageable with concurrent colchicine prophylaxis); gastrointestinal discomfort, including nausea and diarrhoea — substantially reduced by taking with food
- Less common: Maculopapular skin rash — any rash should prompt immediate drug withdrawal and physician review before restarting; drowsiness, headache; altered taste sensation
- Uncommon: Elevated liver enzymes (usually transient and reversible on dose reduction); peripheral neuropathy; alopecia (hair thinning — rare)
- Rare but serious: Allopurinol Hypersensitivity Syndrome (AHS) — severe exfoliative dermatitis, mucositis, hepatitis, and renal failure; this is a medical emergency requiring immediate drug withdrawal and urgent hospital review. Severe bone marrow suppression if combined with azathioprine or 6-MP without appropriate dose reduction of those drugs
Report any skin rash — however mild — promptly to your physician during the first 3 months of therapy. Early recognition of early AHS is critical — a mild rash identified and acted on immediately is manageable; a rash that progresses to full AHS carries significant morbidity and mortality.
Benefits of Buying Zyrik 300mg Online
Managing gout is a long-term commitment measured in years, not weeks — and AllDayChemist makes sustained, uninterrupted therapy both accessible and affordable. When you buy Zyrik 300mg through AllDayChemist, you receive genuine Allopurinol at competitive prices, with the convenience of home delivery that fits your schedule. Our secure, easy-to-use ordering platform, discreet packaging, and dependable international shipping make it straightforward to maintain the continuous therapy that effective gout management demands — without repeat pharmacy visits, supply interruptions, or compromises on the quality of your medication.
Proper dosage and usage guide of Allopurinol 300mg
- Take Zyrik 300mg orally once daily, immediately after a meal — taking with food significantly reduces the gastrointestinal side effects that occasionally occur with Allopurinol
- Swallow the tablet whole with a large glass of water; maintain a total daily fluid intake of at least 2–3 litres to ensure adequate urine output and prevent xanthine crystal formation in the renal tubules (a rare side effect of high-dose Allopurinol)
- Do not start Allopurinol during an acute gout attack — initiation during a flare can prolong and worsen it. Wait until the acute attack has completely resolved (ideally for 2–4 weeks), then begin therapy
- Mobilisation flare prophylaxis: Your physician will typically prescribe concurrent low-dose colchicine (0.5mg once or twice daily) or an NSAID for the first 3–6 months of Allopurinol 300mg therapy. This prophylaxis manages the transient mobilisation flares that occur as crystal deposits dissolve — do not discontinue it prematurely
- Never stop Allopurinol abruptly if already established on therapy, even during a gout attack — stopping causes a rapid rebound rise in serum uric acid that prolongs and worsens the flare. Continue Allopurinol and manage the flare with colchicine or NSAIDs
- Check serum uric acid at 4–6 weeks after starting or changing the dose; the target is below 6 mg/dL (below 5 mg/dL in tophaceous gout). If the target is not achieved at 300mg, your physician may escalate to 400–600mg as tolerated and renal function permits
What is Zyrik 300mg and when is it prescribed?
Zyrik 300mg (Allopurinol 300mg) is a higher-dose formulation used for patients with chronic gout, significantly elevated uric acid levels, or recurrent uric acid kidney stones.
Is Zyrik 300mg more effective than the 100mg dose?
The 300mg dose provides stronger uric acid suppression. Doctors typically titrate from 100mg upward to the minimum effective dose needed to achieve a target uric acid level below 6 mg/dL.
How should Zyrik 300mg be taken?
Take Zyrik 300mg once daily, preferably after a meal, with a full glass of water. Consistent daily use is essential for maintaining uric acid control and preventing gout flares.
Can Zyrik 300mg cause kidney problems?
Allopurinol is generally safe for the kidneys and is used to prevent uric acid kidney stones. However, dose reduction is required in patients with pre-existing kidney disease.
Can I take Zyrik 300mg during a gout flare?
Zyrik should not be started during an acute gout attack. If already taking it when a flare occurs, continue the dose but add anti-inflammatory treatment as prescribed by your doctor.
Where can I order Zyrik 300mg online?
Zyrik can be ordered online from a trusted platform, choose the verified place like AllDayChemist that offer Zyrik 300mg at competitive prices with home delivery. A valid doctor's prescription is required. You can simply upload your prescription and place an order.
How long must I take Zyrik 300mg for gout management?
Allopurinol is a long-term medication for gout. Most patients take it indefinitely to maintain uric acid below the crystallisation threshold and prevent further gout attacks.
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Login
Sign up
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Login
Sign Up
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Forgot Password ?